JFG
GILD icon

Jefferies Financial Group’s Gilead Sciences GILD Stock Holding History

Jefferies Financial Group’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-152,900
Closed -$12.4M – 1754
2023
Q4 		$12.4M Buy
152,900
+34,500
+29% +$2.68M 0.08% 183
2023
Q3 		$8.87M Buy
118,400
+2,400
+2% +$185K 0.08% 189
2023
Q2 		$8.94M Buy
116,000
+11,300
+11% +$901K 0.08% 228
2023
Q1 		$8.69M Buy
104,700
+30,000
+40% +$2.48M 0.07% 240
2022
Q4 		$6.41M Buy
+74,700
New +$5.92M 0.04% 326

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Jefferies Financial Group's GILD Position: Q1 2026 in Review

Jefferies Financial Group reduced its Gilead Sciences (GILD) stake by 45% in Q1 2026, selling an estimated $10.3M and leaving 89,485 shares worth $12.5M. The position accounts for 0.09% of the portfolio, ranked #185.

Jefferies Financial Group first reported a position in GILD in Q4 2022 and has held it in 14 quarters since. The position peaked at $35.3M in Q1 2023. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Jefferies Financial Group held 89,485 shares of Gilead Sciences worth $12.5M as of Q1 2026.
  • Jefferies Financial Group sold 73,906 Gilead Sciences shares in Q1 2026, an estimated $10.3M.
  • Gilead Sciences made up 0.09% of Jefferies Financial Group's portfolio in Q1 2026, its #185 holding.
  • Jefferies Financial Group first reported a position in Gilead Sciences in Q4 2022 and has held it in 14 quarters since.
  • Jefferies Financial Group's Gilead Sciences position peaked at $35.3M in Q1 2023.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Jefferies Financial Group's 13F filing for Q1 2026, filed 8 May 2026.